| New |
| Code |
Description |
| G8930 |
Assessment of depression severity not documented, reason not given |
| G8931 |
Assessment of depression severity not documented, reason not given |
| G8932 |
Suicide risk assessed at the initial evaluation |
| G8933 |
Suicide risk not assessed at the initial evaluation, reason not given |
| G8938 |
Bmi is calculated, but patient not eligible for follow-up plan |
| G8940 |
Screening for clinical depression documented, follow-up plan not documented, patient not eligible/appropriate |
| G8947 |
One or more neuropsychiatric symptoms |
| G8948 |
No neuropsychiatric symptoms |
| G8959 |
Clinician treating major depressive disorder communicates to clinician treating comorbid condition |
| G8960 |
Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
| G8983 |
Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
| G8985 |
Carrying, moving & handling objects functional limitation, projected goal status, at therapy episode outset and at reporting intervals |
| G8986 |
Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
| G8990 |
Other physical or occupational primary functional limitation, current status, at therapy episode outset and at reporting intervals |
| G8991 |
Other physical or occupational primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
| G8992 |
Other physical or occupational primary functional limitation, discharge status, at discharge from therapy or to end reporting |
| G8993 |
Other physical or occupational subsequent functional limitation, current status, at therapy episode outset and at reporting intervals |
| G8994 |
Other physical or occupational subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
| G8995 |
Other physical or occupational subsequent functional limitation, discharge status, at discharge from therapy or to end reporting |
| G8996 |
Swallowing functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G8997 |
Swallowing functional limitation, projected goal status, at initial therapy treatment/outset and at discharge from therapy |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy/end of reporting on limitation |
| G8999 |
Motor speech functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9157 |
Transesophageal doppler use for cardiac monitoring |
| G9158 |
Motor speech functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9159 |
Spoken language comprehension functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9160 |
Spoken language comprehension functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9161 |
Spoken language comprehension functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9162 |
Spoken language expression functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9163 |
Spoken language expression functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9164 |
Spoken language expression functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9165 |
Attention functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9166 |
Attention functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9167 |
Attention functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9168 |
Memory functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9169 |
Memory functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9170 |
Memory functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9171 |
Voice functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9172 |
Voice functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9173 |
Voice functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9174 |
Other speech language pathology functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals |
| G9175 |
Other speech language pathology functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9176 |
Other speech language pathology functional limitation, discharge status at discharge from therapy/end of reporting on limitation |
| G9186 |
Motor speech functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy |
| G9232 |
Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason |
| C9458 |
Florbetaben F18, diagnostic, per study dose, up to 8.1 millicuries |
| C9459 |
Flutemetamol F18, diagnostic, per study dose, up to 5 millicuries |
| E1012 |
Wheelchair accessory, addition to power seating system, center mount power elevating leg rest/platform, complete system, any type, each |
| G9509 |
Remission at twelve months as demonstrated by a twelve month (+/-30 days) PHQ-9 score of less than 5 |
| G9510 |
Remission at twelve months not demonstrated by a twelve month (+/-30 days) PHQ-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5 |
| G9511 |
Index date PHQ-9 score greater than 9 documented during the twelve month denominator identification period |
| G9512 |
Individual had a PDC of 0.8 or greater |
| G9513 |
Individual did not have a PDC of 0.8 or greater |
| G9531 |
Patient has a valid reason for a head CT for trauma being ordered, regardless of indications (i.e., ventricular shunt, brain tumor, multisystem trauma, pregnancy, or currently taking an antiplatelet medication including: asa/dipyridamole, clopidogrel, prasugrel, ticlopidine, ticagrelor or cilstazol) |
| G9532 |
Patient's head injury occurred greater than 24 hours before presentation to the emergency department, or has a GCS score less than 15, or had a head CT for trauma ordered by someone other than an emergency care provider, or was ordered for a reason other than trauma |
| G9534 |
Advanced brain imaging (CTA, CT, MRA or MRI) was not ordered |
| G9535 |
Patients with a normal neurological examination |
| G9536 |
Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); HIV-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms) |
| G9537 |
Documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study) |
| G9538 |
Advanced brain imaging (CTA, CT, MRA or MRI) was ordered |
| G9572 |
Index date PHQ-score greater than 9 documented during the twelve month denominator identification period |
| G9573 |
Remission at six months as demonstrated by a six month (+/-30 days) PHQ-9 score of less than five |
| G9574 |
Remission at six months not demonstrated by a six month (+/-30 days) PHQ-9 score of less than five. either PHQ-9 score was not assessed or is greater than or equal to five |
| G9580 |
Door to puncture time of less than 2 hours |
| G9581 |
Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of CVA for endovascular stroke treatment; hospitalized patients with newly diagnosed CVA considered for endovascular stroke treatment) |
| G9582 |
Door to puncture time of greater than 2 hours, no reason given |
| G9593 |
pca patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules |
| G9594 |
Patient presented within 24 hours of a minor blunt head trauma with a GCS score of 15 and had a head CT ordered for trauma by an emergency care provider |
| G9595 |
Patient has a valid reason for a head CT for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia) |
| G9596 |
pca patient's head injury occurred greater than 24 hours before presentation to the emergency department, or has a GCS score less than 15, or had a head CT for trauma ordered by someone other than an emergency care provider, or was ordered for a reason other than trauma |
| G9597 |
pca patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules |
| G9635 |
Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the HRQOL survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire) |
| G9646 |
Patients with 90 day MRS score of 0 to 2 |
| G9647 |
Patients in whom MRS score could not be obtained at 90 day follow-up |
| G9648 |
Patients with 90 day MRS score greater than 2 |
| J7340 |
Carbidopa 5 mg/levodopa 20 mg enteral suspension |
| G9717 |
Documentation stating the patient has an active diagnosis of depression or has a diagnosed bipolar disorder, therefore screening or follow-up not required |
| G9742 |
Psychiatric symptoms assessed |
| G9743 |
Psychiatric symptoms not assessed, reason not otherwise specified |
| G9766 |
Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment |
| G9767 |
Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment |
| G9770 |
Peripheral nerve block (pnb) |
| J1942 |
Injection, aripiprazole lauroxil, 1 mg |
| Q9982 |
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries |
| Q9983 |
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries |
| S0311 |
Comprehensive management and care coordination for advanced illness, per calendar month |
| T1040 |
Medicaid certified community behavioral health clinic services, per diem |
| T1041 |
Medicaid certified community behavioral health clinic services, per month |
| C9014 |
Injection, cerliponase alfa, 1 mg |
| J2326 |
Injection, nusinersen, 0.1 mg |
| J2350 |
Injection, ocrelizumab, 1 mg |
